YAF2
Basic information
Region (hg38): 12:42157103-42238349
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the YAF2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 11 | 11 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 11 | 1 | 0 |
Variants in YAF2
This is a list of pathogenic ClinVar variants found in the YAF2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-42160620-T-C | not specified | Uncertain significance (May 31, 2022) | ||
12-42160638-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
12-42160645-A-G | not specified | Uncertain significance (Jul 20, 2022) | ||
12-42160678-C-T | not specified | Uncertain significance (Oct 31, 2023) | ||
12-42160752-A-G | not specified | Uncertain significance (Mar 06, 2023) | ||
12-42161655-T-A | not specified | Uncertain significance (May 26, 2024) | ||
12-42210599-A-G | not specified | Uncertain significance (Nov 18, 2022) | ||
12-42210608-A-G | not specified | Uncertain significance (Oct 06, 2021) | ||
12-42235898-C-T | Likely benign (Apr 01, 2023) | |||
12-42237632-A-G | not specified | Uncertain significance (Jun 13, 2023) | ||
12-42237651-C-G | not specified | Uncertain significance (Dec 15, 2023) | ||
12-42237690-C-T | not specified | Uncertain significance (May 11, 2022) | ||
12-42237698-G-A | not specified | Uncertain significance (Apr 15, 2024) | ||
12-42238158-G-A | not specified | Uncertain significance (Oct 12, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
YAF2 | protein_coding | protein_coding | ENST00000442791 | 5 | 81246 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.795 | 0.204 | 125524 | 0 | 1 | 125525 | 0.00000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.56 | 57 | 101 | 0.563 | 0.00000488 | 1319 |
Missense in Polyphen | 16 | 42.024 | 0.38073 | 563 | ||
Synonymous | 0.750 | 32 | 37.9 | 0.845 | 0.00000197 | 370 |
Loss of Function | 2.57 | 1 | 9.60 | 0.104 | 4.72e-7 | 126 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000881 | 0.00000881 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Binds to MYC and inhibits MYC-mediated transactivation. Also binds to MYCN and enhances MYCN-dependent transcriptional activation. Increases calpain 2-mediated proteolysis of YY1 in vitro. Component of the E2F6.com-1 complex, a repressive complex that methylates 'Lys-9' of histone H3, suggesting that it is involved in chromatin-remodeling. {ECO:0000269|PubMed:11593398, ECO:0000269|PubMed:12706874, ECO:0000269|PubMed:9016636}.;
- Pathway
- Gene expression (Transcription);RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;Transcriptional Regulation by E2F6;Generic Transcription Pathway;RNA Polymerase II Transcription;Transcriptional regulation by RUNX1
(Consensus)
Recessive Scores
- pRec
- 0.108
Haploinsufficiency Scores
- pHI
- 0.168
- hipred
- Y
- hipred_score
- 0.816
- ghis
- 0.611
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.919
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Low | Low | Low |
Primary Immunodeficiency | Low | Low | Low |
Cancer | Low | Low | Low |
Mouse Genome Informatics
- Gene name
- Yaf2
- Phenotype
Gene ontology
- Biological process
- negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;negative regulation of G0 to G1 transition
- Cellular component
- nucleus;nucleoplasm;cytosol
- Molecular function
- transcription coactivator activity;transcription corepressor activity;protein binding;metal ion binding